EUVIMEDEUVIMED entdecken
Crossref

Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary

Ben Sessa, Friederike Meckel Fischer

Drug Science, Policy and Law · 2016

DOI: 10.1177/2050324515578080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Science, Policy and Law, 2016. Verfasst von Ben Sessa und 1 weiteren Autor:innen. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Underground psychedelic-assisted psychotherapy has persisted in Europe despite the banning of the substances LSD and MDMA in the 1960s and 1980s, respectively. This article describes the work of a Zurich-based psychotherapist providing individual and group psycholytic psychotherapy, whose practice persisted for several years before she was arrested in 2009. The article provides commentary on the psychopharmacological, moral, ethical and legal issues of this case and discusses these issues in the context of the growing medical research of psychedelic substances as mainstream treatments for psychiatry.

Zitieren

APA

Sessa, B., & Fischer, F. M. (2016). Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary. Drug Science, Policy and Law. https://doi.org/10.1177/2050324515578080

Vancouver

Sessa B, Fischer FM. Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary. Drug Science, Policy and Law. 2016. doi:10.1177/2050324515578080

BibTeX
@article{Sessa2016,
  author = {Sessa, Ben and Fischer, Friederike Meckel},
  title = {Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary},
  journal = {Drug Science, Policy and Law},
  year = {2016},
  doi = {10.1177/2050324515578080}
}
Kostenlos starten →